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 Breast cancer is one of the malignant tumors that begins in the breast cells that 
develop and attack the surrounding tissues; according to World Health 
Organization (WHO), breast cancer is globally declared the top five killer cancers. 
In Indonesia, breast cancer becomes the number one killer cancer.  One of the 
successes in breast cancer treatment is if the cure obtained by cancer patients can 
be proven to have the same life expectancy as those who do not have breast cancer. 
This study aims to know the probability of survival of breast cancer patients and 
know the factors that affect breast cancer patients' survival. The data were consist 
of 394 medical records of breast cancer patients at Dr. Soetomo Hospital Surabaya 
in the period January 2018 – December 2019, with variables used, i.e., initial age of 
infection, clinical stage, tumor size, metastatic to other organs, type of treatment, 
and patient status (life or death). This study using Kaplan Meier and Cox 
Proportional Hazard regression methods, and the result showed that the 
probability of survival of breast cancer patients (with data samples) was 0.737 or 
73.7%. The variables that significantly affect breast cancer patients' survival are 
the initial age of infection, the clinic stage, and the tumor's size. This research 
provides information and motivation to the community related to life expectancy, 
especially in breast cancer patients, to stay motivated in the healing process. In 
addition, this research is also used to add insight to academics, especially the 
department of statistics, regarding the regression of Cox Proportional Hazard in 
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A. INTRODUCTION  
Breast cancer is one type of cancer in women and is still a health problem in women 
worldwide and the second most common malignancy disease that causes death. Breast cancer 
is a disease derived from malignant cells that form tumors and are then detected in breast tissue. 
Malignant tumors can develop in breast tissue such as mammary glands, milk ducts, fat tissue, 
and other connective tissues (Reyna & Lee, 2014) (Sun et al., 2017). Breast cancer affects the 
breast's glands, ducts, and tissues but does not include its skin. Cancer-detecting breast cells 
and tissues will make changes in the shape of those cells and tissues abnormal and multiply 




uncontrollably (Dewi & Hendrati, 2015). In general, the main complaint in patients with breast 
cancer is swelling of the breast. Initially, the lump is small, but the longer it grows and attaches 
to the skin or causes changes to the skin of the breast or nipple (Ghodsi, Salehi, & Hojjatoleslami, 
2013). 
Various factors are the reason for breast cancer, genetic, family, hormonal, and obesity 
factors. The World Health Organization (WHO) in 2004 stated that there are five significant 
cancers in the world, namely lung cancer, breast cancer, colon cancer, gastric cancer, and liver 
cancer. A survey was conducted by who stated that a person with breast cancer is 8-9% in 
women. In 2012 there was an increase in the incidence of breast cancer globally; 1.7 million 
women were diagnosed with breast cancer, and 6.3 million women were diagnosed with breast 
cancer in the previous five years. Since 2008 there has been an estimated 20% increase in 
breast cancer incidence, with a 14% increase in mortality, until the occurrence of a specific 
event called failure event. Every year, over 1.5 million women worldwide (25 percent of all 
cancer patients) are diagnosed with breast cancer (Kleibl & Kristensen, 2016) (Sun et al., 2017). 
Based on Globocan data, in 2018, cancer is the second leading cause of death globally and is 
responsible for about 9.6 million deaths. While in Indonesia, in the same year amounted to 
207,210. The incidence of cancer in Indonesia (136.2/100,000 inhabitants) is 8th in Southeast 
Asia. While in Asia, it ranks 23rd, Indonesia's highest incidence rate for men is lung cancer, 19.4 
per 100,000 inhabitants, with an average mortality of 10.9 per 100,000 inhabitants. The second 
place is liver cancer of 12.4 per 100,000 inhabitants, with an average mortality of 7.6 per 
100,000 inhabitants. At the same time, the highest incidence rate for women is breast cancer at 
42.1 per 100,000 inhabitants, with an average mortality of 17 per 100,000 inhabitants. The 
second place is cervical cancer of 23.4 per 100,000 inhabitants, with an average mortality of 
13.9 per 100,000 inhabitants (K. kesehatan RI, 2020)(D. P. K. kesehatan RI, 2019).  
High breast cancer cases are caused because breast cancer patients are often unaware of or 
feel breast cancer symptoms. If breast cancer is detected in the advanced stage, more expensive 
treatment, more difficult treatment results are not maximal and even accelerate death. One of 
the successes in breast cancer treatment is if the cure obtained by cancer patients can be proven 
to have the same life expectancy as the population who do not have breast cancer. The 
benchmark for successful cancer treatment is the patient's survival rate. One of the most 
commonly used methods is Kaplan Meier's analysis, followed by a Log Rank test and Cox 
Proportional Hazard regression.  
Survival analysis (endurance analysis) is a statistical method in which the variable that is 
observed is a variable of time until the occurrence of events (died) or commonly called survival 
time (Ihwah, 2015). One of the most widely used methods is Kaplan Meier's analysis, followed 
by a Log Rank test and Cox Proportional Hazard regression. Kaplan Meier's analysis is used to 
assess survival functions. In contrast, the Log Rank test is used to test whether there is a 
difference in the survival curve Kaplan Meier. Meanwhile, Cox Proportional Hazard's regression 
is used to determine the combination of factors that affect his response in survival time. 
The key to problem analysis to consider in resiliency analysis is the censored data. The 
censored data is not discarded but still considered because the minimum up to a certain point 
can still be seen as having not experienced the event and assuming that sensor events within a 
specific time occur evenly. Three factors must be considered in determining survival time. First, 
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the start point cannot be ambiguous, or there are no two or more meanings. Second, the event 
of the whole affair should be clear. Third, the scale of survival time measurement should be 
precise  (Nurfain & Purnami, 2017) (Ebrahimi et al., 2019). 
Some studies on life resilience analysis include Yulianto, Notobroto, & Widodo (2017), 
conducted the survival analysis of Chronic Kidney Disease (CKD) patients with hemodialysis at 
Dr. Soetomo Surabaya period 2010-2013 using Kaplan Meier test and Log Rank. The results of 
the study stated that CKD patients undergoing hemodialysis at Dr. Soetomo Hospital, with the 
age range of 46-65 years, have a history of hypertension and diabetes mellitus would have a 
lower average survival compared to patients aged between 26-45 years and have no record of 
both diseases.  Wijaya & Wulandari (2015) also conducted survival analysis in patients with 
Acute Coronary Syndrome (ACS) at Dr. Soetomo Hospital Surabaya in 2013 using Cox 
Proportional Hazard Regression. The results of the study stated that on the 5th to 10th day, it 
was possible that the patient did not experience clinical improvement, and the factors that 
influenced the rate of clinical improvement of SKA patients were dyslipidemia status, diabetes 
mellitus, hypertension, and hemodynamic profile. Similar research was also conducted by 
Nurfain & Purnami (2017), which analyzed Cox Extended regression in leprosy patients in 
Brondong Subdistrict Lamongan district in 2012-2015 190th day, many patients experienced 
clinical improvement, and they declared Release From Treatment (RF).  
Yadav et al. (2021) conducted a survival analysis between men and women with triple-
negative breast cancer (TNBC). In this study, the baseline demographic and cancer 
characteristics of men and women were compared using the Pearson's Chi-Square test for 
categorical variables and the Mann-Whitney U test for continuous variables in this paper. A 
Kaplan Meier and multivariate Cox proportional hazards regression model were applied in this 
study to compare survival and find prognostic markers. The result of this paper shows that 3-
year and 5-year overall survival rates in men were 74.8 percent and 68.8 percent, respectively, 
while women's rates were 83.2 percent and 74.8 percent. Men had a considerably worse overall 
survival rate than women (HR: 1.49, 95 percent CI: 1.19-1.86, p =0.01), according to 
multivariate analysis. In men with TNBC, older age at diagnosis, higher TNM stage, mastectomy, 
and lack of chemotherapy or radiation were independent negative prognostic markers.  
Jawitz et al. (2020) used survival analysis to examine recipient survival under the new 
system using an updated dataset. In this study, the Kaplan-Meier technique and multivariable 
Cox proportional hazards regression were used to investigate the relationship between the 
allocation system and recipient mortality. According to the findings of this study, the short-term 
survival of recipients listed and receiving a transplant under the old and new allocation 
processes appears to be equal. The alteration in the allocation system has resulted in several 
changes in the clinical characteristics of patients undergoing transplants, which will need to be 
constantly studied in future years.   
Han et al. (2021) used the Cox regression model to find characteristics that predicted DNS 
development. Kaplan–Meier curves were created to quantify the cumulative incidence of DNS. 
The key predictors of DNS development were identified using a multivariate Cox regression 
model. According to the findings of this study, the incidence of DNS was 18.8%, with a median 
onset time of 23.7 days (interquartile range, 14–30 days). A higher cumulative incidence of DNS 
was related with a blood creatine kinase (CK) level > 175.5 U/L, and an initial Glasgow Coma 




Scale (GCS) score of 9 (log-rank test; p = 0.02, respectively). A serum CK level > 175.5 U/L 
(hazard ratio [HR]: 2.862, 95 percent confidence interval [CI]: 1.491–5.496; p = 0.01) and an 
initial GCS of 9 (HR: 2.081, 95 percent confidence interval [CI]: 1.048–4.131; p = 0.04) were 
significant prognostic variables, according to Cox regression analysis. 
Based on the research above, the Kaplan Meier method of Log Rank test and Cox 
Proportional Hazard regression is a powerful and widely used survival analysis approach. The 
ability to display unadjusted and adjusted HRs (hazard ratios) with their corresponding CIs is 
the main benefit of Cox regression analysis (confidence interval). Other than that, Cox 
Proportional Hazard regression does not have assumptions about properties and shapes 
according to the distribution as assumptions in the other regressions (Stel, Dekker, Tripepi, 
Zoccali, & Jager, 2011) (Julia, 2012). Because of that, in this study, the Cox Proportional Hazard 
regression and the Kaplan Meier method were used to analyzing breast cancer patients' 
survival. This study's results are expected to help determine the probability of survival of breast 





This study uses secondary data from the medical record section in Dr. Soetomo Hospital 
Surabaya from January 2018 until December 2019. The data acquired amounted to 349 patients 
with details of 201 patients still surviving, 91 patients have died, and 57 patients are missing 
from observation. Here is a description of the variables used in the study. 
Table 1.  Research Variables 
Variables Description 
T Survival Time (days) The time during the patient undergoing hospital treatment  
0 = if the patient is missing from the research time and the 
patient is still surviving  
1 = if the patient dies 
X1 Age (Years) Early age of infection 
X2 Stadium 1 = Early stage (0, I, and II) 
2 = Advanced stage (III and IV) 
X3 Tumor Size 1 = ≤5 cm 
2 = >5 cm 
X4 Metastasis 0 = have not Metastasis 
1 = have Metastasis 
X5 Types of Treatment 1 = Radiotherapy 
2 = Chemotherapy 
 
 
2. Data Analysis 
Data analysis techniques are the steps to solve problems from start to finish. Data analysis 
techniques in this study, namely as follows: 
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a. Collection of breast cancer data obtained from the medical records section in Dr. 
Soetomo Hospital Surabaya during January 2018 – December 2019.  
 
b. Describe breast cancer patients' characteristics based on survival time and factors that 
affect their survival.  
1) Survival Function 
The 𝑆(𝑡) survival function is defined as the probability of an object surviving from a 
survival time greater than or equal to t. The survival function can also be described 
as a smooth graph/curve, with 𝑆(𝑡) being the column and t being the row. In this case, 
the chart/curve may decrease from 𝑆(𝑡) = 1   at 𝑡 = 0 to 𝑆(𝑡) = 0 on  𝑡 = ∞. In other 
words, at the time = 0, life chance = 1, and at an infinite time, his life chance = 0. 
Suppose T is a random variable that symbolizes survival time and has the function 
of 𝑓(𝑡), opportunity distribution, so (Kartsonaki, 2016). 
𝑆(𝑡)   = 𝑃(𝑇 > 𝑡) 
          = 1 − 𝑓(𝑡) = 1 − 𝑃(𝑇 ≤ 𝑡)      (1) 
2) Hazard Function 
The Hazard ℎ(𝑡) function defines a momentary failure rate assuming that an object 
reaches an event at a time interval of 𝑡 to (𝑡 + ∆𝑡), provided that it has survived until 
that time (Kartsonaki, 2016). So obtained: 
ℎ(𝑡) = lim
∆𝑡→0
𝑃(𝑖𝑛𝑑𝑖𝑣𝑖𝑑𝑢𝑎𝑙𝑠 𝑖𝑛 𝑡 𝑒𝑥𝑝𝑒𝑟𝑖𝑒𝑛𝑐𝑒 𝑒𝑣𝑒𝑛𝑡𝑠 𝑖𝑛 𝑡ℎ𝑒 ℎ𝑜𝑠𝑒 (𝑡, 𝑡 + ∆𝑡))
∆𝑡
 



























         (2) 
So that it can be stated the relationship between survival function and hazard 




           (3) 
c. Describe the survival curve of breast cancer patients with Kaplan Meier's analysis 
Suppose there are n breast cancer individuals observed with long life, 𝑡1,𝑡2, … , 𝑡𝑛 and 
there is a 𝑗 individual who dies  (𝑗 ≤ 𝑛) in the order of the time of death 𝑡(1) ≤ 𝑡(2) ≤




⋯ ≤ 𝑡(𝑗). Meanwhile 𝑛(𝑗) is the number of individuals at risk of dying at 𝑡(𝑗) and 𝑑(𝑗) are 
individuals who die at  𝑡(𝑗).  Thus the estimate of Kaplan Meier ?̂?(𝑡) is as follows (Zare et 
al., 2014): 
?̂?(𝑡) = ∏ (1 −
𝑑(𝑗)
𝑛(𝑗)
)𝑡(𝑗)≤𝑡                                 (4) 
The Log Rank test is used in comparing whether there is a difference between Kaplan 
Meier's survival curves. Here are the hypotheses in the Log Rank test: 
H0: There is no difference in Kaplan Meier's survival curve between different groups. 
H1: There is at least one difference in Kaplan Meier's survival curve between other 
groups. 
With test statistics as follows: 





𝑖=1           (5) 
















𝑗−1 )        (7) 
Where 𝐺  is the number of groups; 𝑂𝑖  is individual observation values of the i; 𝐸𝑖  is 
individual expectation values of the group to i; 𝑚𝑖𝑗  is the number of subjects who died 
in the i group at the time of 𝑡(𝑗); 𝑛𝑖𝑗 is the number of subjects at risk of dying in the i 
group at the time of 𝑡(𝑗); and 𝑒𝑖𝑗 is individual expectation values of the i group at the 
time of 𝑡(𝑗). Decision making for this statistics is H0 rejected if  𝜒
2>𝜒(𝛼;𝐺−1)
2  or p-value < 
𝛼 = 0.05 (Kleinbaum & Klein, 2012)  
 
d. Test the differences in breast cancer patients' survival curve based on the results in the 
second step with the Log Rank test  with Equations (5) 
 
e. Test proportional hazard assumptions. 
The proportional failure function assumes that the failure ratio function should be 
constant over time (Dwidayati, 2016). The way to test the hypothesis of proportional 
failure is by visual test and formal test. 
1) Visual Test 
Determining the assumption of proportional failure on visual tests can use Kaplan 
Meier's survival curve approach. The survival curve is said not to meet proportional 
hazard assumptions when the survival lines between groups intersect. The survival 
curve meets proportional hazard assumptions when the survival lines between 
groups do not intersect  (Selvaraj et al., 2014). 
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2) Formal Test 
Determining the assumption of failure proportional to a formal test can be 
approached with a Goodness of Fit (GoF) test. There are three steps that must be 
taken in GoF testing. First, regress survival time with its free variables to obtain 
Schoenfeld residual values. Second, create time variables that have been sorted from 
smallest to largest. Third, test the correlation between Schoenfeld residuals and 
sorted time variables. The hypothesis that uses in this test is:  
H0: ρ = 0 (Assumptions of proportional failure are met);  
H1:ρ≠0 (Assumptions of proportional failure are not met).  
With the decision making is H0 rejected if P-value > α=5% (Zhou, Fine, & Laird, 2013).  
 
f. Create a Cox Proportional Hazard regression model 
Modeling survival data using the cox proportional hazard model uses a parametric 
method to estimate the covariate effect on survival data. Cox's regression is used to 
determine the influencing factors in survival data for uncensored data (Lee, Moon, & 
Salamatian, 2012). If 𝑋  is a vector-sized 𝑝 × 1  where the elements are covariate 
𝑋1, 𝑋2, … , 𝑋𝑝, then the Cox Proportional Hazard model is 
ℎ𝑖(𝑡𝑗|𝑋) = ℎ0(𝑡|𝑋) exp(𝛽1𝑋1𝑖 + 𝛽2𝑋2𝑖 + ⋯ + 𝛽𝑝𝑋𝑝𝑖) 
             = ℎ0(𝑡) exp ∑ 𝛽𝑗𝑥𝑗𝑖
𝑝
𝑗=1                                                                                       (8) 
Where 𝑋  is (𝑋1, 𝑋2, … , 𝑋𝑝)  is an explanatory/predictor variable; ℎ0(𝑡)  is basic failure 
function; ℎ𝑖(𝑡𝑗|𝑋) is individual failure function i; 𝑥𝑗𝑖 is variable value j from individual i, 
with 𝑗 = 1,2, … , 𝑝 and 𝑖 = 1,2, … , 𝑛; and 𝛽𝑗 is regression coefficient j, with 𝑗 = 1,2, … , 𝑝. 
 
g. Test parameters with the Likelihood Ratio test  
Parameter testing determines whether independent variables affect dependent 
variables (Yi & Wang, 2011). 
1) Simultaneous Testing (Likelihood Ratio Testing) 
Hypothesis: 
H0 : 𝛽1 = 𝛽2 = ⋯ = 𝛽𝑝 = 0 (no variables significantly affect) 




2 = 2 𝑙𝑜𝑔𝐿𝑣 − 2 log 𝐿0       (9) 
Where 𝐿𝑣 is likelihood function value with the independent variable; 𝐿0 is likelihood 
function value with the independent variable; and 𝑝 is the number of parameters 𝛽. 
With decision making is H0 rejected if  𝜒𝐿𝑅
2 >𝜒𝑝;𝛼
2  or p-value < α=5%. 
 
2) Partial Testing (Wald Testing) 
Hypothesis: 
H0 : 𝛽𝑗 = 0, with 𝑗 = 1,2, … , 𝑝 (j – variable has no significant effect) 




H1 : 𝛽𝑗 ≠ 0, (j – variable has no significant impact) 
Test statistics: 
𝜒𝑊𝑎𝑙𝑑





                  (10) 
𝑆𝐸 (?̂?𝑗) =  √𝑣𝑎𝑟(?̂?𝑗)                  (11) 
Where 𝑆𝐸 (?̂?𝑗) is deviation standard from ?̂?𝑗; and 𝑣𝑎𝑟(?̂?𝑗) is variance from ?̂?𝑗. With 
decision making is H0 rejected if  𝜒𝑊𝑎𝑙𝑑
2 >𝜒1;𝛼
2  or p-value< α=5%. 
 
h. Calculate hazard ratio  
The hazard ratio is the failure of one group of individuals divided by the inability of 
different individuals failure. Two groups of compared individuals are distinguished by 
their dependent variables (Uno et al., 2015). Calculating hazard ratios can use standard 
equations for hazard function, i.e (Lee et al., 2012) (Devarajan & Ebrahimi, 2011).  
𝐻(𝑡) = 𝐻0(𝑡)𝑒




                      (13) 
Where 𝐻𝑅  is hazard ratio; 𝐻(𝑡)  is a hazard at any given time; 𝐻0(𝑡)  is the baseline 
hazard at any given time; 𝑒 is natural number = 2.714; and 𝐻(𝑡)∗ is a hazard at any given 
time for one group of individuals 
 
C. RESULT AND DISCUSSION 
1. Kaplan Meier's Survival Curve 
This descriptive analysis using Kaplan Meier's survival curve is used to determine the 
survival picture of breast cancer patients in general. Before drawing the survival curve of 
Kaplan Meier, calculating the probability of breast cancer patients' survival for two years using 
Equation (5). After getting the results from estimating the probability of each time with 
Equation (5), the next Kaplan Meier survival curve will be made, as shown in Figure 1. 




Figure 1. Kaplan Meier's Survival Curve Breast Cancer Patient 
 
Figure 1 obtained survival curve decreased slowly, meaning that the curve explained that a 
lot of censored data or a lot of data that did not experience the event that is breast cancer 
patients who died during the study time is two years. It means that there are still many breast 
cancer patients who still survive in the space of two years. Based on these calculations, the 
results are that the probability of survival of breast cancer patients over two years is still high 
at 0.737 or 73.7%. 
The following will explain breast cancer patients' characteristics based on suspected factors 
to affect her using the Kaplan Meier survival curve. To get the probability value in each early 
age group contracting breast cancer can be calculated using Equation (5). From the research 
data, the initial age of infection in breast cancer patients was divided into four groups, namely 
patients with the initial age of contracting 31-40 years, 41-50 years, 50-60 years, and >60 years. 
After getting the results of the calculation of the probability of each time, the Kaplan Meier 
survival curve for breast cancer patients will be made based on the initial age of infection, as 
shown in Figure 2.  
 
Figure 2. Kaplan Meier's Survival Curve Based on Early Infected Age 




Based on Figure 2 graphically, it appears that breast cancer patients with early age 31-40 
years have a probability of survival between 0.4 to 1. It can be said that the patient's survival is 
low. Breast cancer patients with early age 41-50 years, 51-60 years, and >60 years have a 
probability of survival between 0.7 to 1. It can be said that the patient's survival is relatively 
high. When viewed from the likelihood of survival of breast cancer patients of early age infected 
30-40 years by 0.656 or 65.6%, the initial age of contracting 41-50 years is 0.747 or 74.7%, the 
initial age of contracting 51-60 years is 0.801 or 80.1% and the initial age of contracting >60 
years is 0.778 or 77.8%. Based on this explanation, it is suspected that there are no differences 
in the survival curves for the four age groups of patients when they first contracted breast 
cancer.  
The Log Rank test can be used to determine whether there is a difference in survival time in 
the early infected age group. The calculation of the Log Rank test can use the formula in 
Equation (6). The analysis found that the highest survival of patients is seen in patients whose 
initial age is more than 50 years old, and the lowest occurs in the early age of the infection 30 – 
40 years. Similar to the research conducted by Suganda et al. (2021) showed the highest 
survival rate occurred at the initial age of disease, more than 60 years, namely 74.1%. Breast 
cancer is common in women aged 45 and over but has recently shifted, with breast cancer 
affecting women aged 20 to 30 more (Arshi et al., 2018). Low survival of patients with early age 
breast cancer under 40 years is associated with hormonal factors that are still active, so the risk 
of developing breast cancer becomes higher. It can also be linked to the tumor's size when 
detected, or cancer cells attack much more malignantly. Patients with early age breast cancer 
over 60 years old are usually associated with the body's condition, weakened cells, or other 
disease factors (Jobsen et al., 2019). 
After the age factor, the next factor that needs to be reviewed is the clinical stage factor. The 
clinical-stage is one of the factors that affect the survival of breast cancer patients. Clinical 
staging in breast cancer patients is divided into two groups: early and advanced. To get the 
probability value in each stage group can be calculated using Equation (5). After getting the 
results from estimating the probability of each time, the next Kaplan Meier survival curve for 
breast cancer patients will be made based on the clinical stage, as shown in Figure (3).   
 
Figure 3. Kaplan Meier's Survival Curve Based on Clinical Stage 
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Based on Figure 3 graphically, it appears that breast cancer patients with early-stage from 
early admission up to 720 days have a higher probability of survival between 0.9 to 1. It can be 
said that the patient's survival is high. Breast cancer patients with advanced stages from the 
beginning of entry have a decreased curve with a probability of between 0.3 to 1. The patient 
has low survival, which is viewed from the probability of survival of early-stage breast cancer 
patients by 0.944 or 94.4%, advanced patients by 0.503 or 50.3%. Based on this explanation, it 
is suspected that there are differences in the survival curves for the two-stage groups.  
To determine whether there is a difference in survival time at the clinical stage, the Log 
Rank test can be used. Calculation of the Log Rank test can use the formula in Equation (6). The 
highest patient survival is found in patients with an early stage, and the survival of patients with 
advanced stages is very low, and there is a difference in the proportion of survival of breast 
cancer patients with research conducted by Suganda et al. (2021) showing the low survival of 
advanced-stage patients with the probability of survival is 46.6%. The low survival of advanced 
patients is due to the advanced stage has involved more life nodes, while the lymph nodes 
themselves have a role as the body's defense system. Also, in the advanced stages of cancer that 
attacks the patient has spread to other organs that impact the impaired function of the body 
organs and the vulnerability of sufferers to infection. 
The next factor is the tumor size factor. Tumor size is one of the factors that affect the 
survival of breast cancer patients. Tumor size in breast cancer patients was divided into two 
groups, namely 5 cm and > 5 cm. Get the probability value in each group of tumor size can be 
calculated using Equation (5). After getting the results from estimating the probability of each 
time, the next Kaplan Meier survival curve for breast cancer patients will be made based on the 
Tumor size factors as shown in Figure 4.  
 
Figure 4. Kaplan Meier's Survival Curve Based on Tumor Size 
Based on Figure 4, it is shown that breast cancer patients with tumor size ≤5 cm from initial 
admission up to 720 days have a higher probability of survival between 0.8 to 1. It can be said 
that the patient's survival is high. For breast cancer patients with tumor size >5 cm from start 
to finish decreased with a probability of survival of 0.3 to 1, meaning that the patient has a low 
survival. Others, if the probability of survival of breast cancer patients with a tumor size of ≤5 




cm by 0.877 or 87.7%, and patients with tumor size >5cm by 0.434 or 43.4%. Based on this 
explanation, it is suspected that there are differences in the survival curves for the two tumor 
size groups.  
To determine whether there is a difference in survival time on tumor size, the Log Rank test 
can be used. The calculation of the Log Rank test can use the formula in Equation (6). The result 
shows that low survival of breast cancer patients with tumors of >5 cm is commonly associated 
with distant lymph nodes. The larger the size of the detected tumor, the more positive node 
lymph. When the patient receives treatment when the tumor's size has enlarged, the treatment 
rate becomes lower. There are residual tumors after operative therapy, where the large number 
of tumors that remain can cause recurrence rates in breast cancer patients (Yao et al., 2020).  
The next factor is metastasis. Metastasis is one of the factors that affect the survival of breast 
cancer patients. Metastases in breast cancer patients were divided into two groups, namely 
those with metastases and no metastases. To get the probability value in each group of 
metastases can be calculated using Equation (5). After getting the results from estimating the 
probability of each time, the next Kaplan Meier survival curve for breast cancer patients will be 
made based on the metastasis factors, as shown in Figure 5.  
 
 
Figure 5. Kaplan Meier's Survival Curve Based on Metastasis 
Based on Figure 5, it is graphically seen that breast cancer patients who do not get 
metastasis have a higher probability of survival between 0.9 to 1. It can be said that the patient's 
survival is high. However, breast cancer patients with metastatic cancer have a probability of 
between 0.4 to 1. It means that the patient's survival is low when viewed from the probability 
of survival of breast cancer patients who do not have metastases by 0.907 or 90.7%, and 
patients with metastases of 0.527 or 52.7%. Based on this explanation, it is suspected that there 
are differences in the survival curves for the two metastases.  
To find out whether there is a difference in survival time in metastases, the Log Rank test 
can be used. Calculation of the Log Rank test can use the formula in Equation (6). The result 
shows that breast cancer patients with cancer cells that have spread have a low survival rate of 
57.2%, while patients who do not have metastases have a high survival. Because in patients 
with metastases, there is often a spread to internal organs such as the lungs, brain, bones, etc. 
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This causes the organ's malfunction, affecting breast cancer patients' survival (Febriani & 
Furqon, 2018). 
The last factor is the type of treatment, the kind of treatment is one of the factors that affect 
the survival of breast cancer patients. Types of treatment in breast cancer patients are divided 
into two groups, namely radiotherapy, and chemotherapy. To get the probability value for each 
group of the kinds of treatment can be calculated using the formula in Equation (5). After 
getting the results from calculating the probability of each time, the Kaplan Meier survival curve 
for breast cancer patients will then be made based on the type of treatment as shown in Figure 
6.   
 
Figure 6. Kaplan Meier's Survival Curve By Treatment Type 
Based on Figure 6, it is graphically seen that breast cancer patients undergoing treatment 
with radiotherapy from early admission to 720 days have a higher probability of survival 
between 0.7 to 1. It can be said that the patient's survival is high. Breast cancer patients 
undergoing treatment with chemotherapy had a higher probability of survival between 0.6 to 
1. It can be said that the patient's survival is relatively high. The probability of survival of breast 
cancer patients undergoing treatment with radiotherapy by 0.792 or 79.2%. The probability of 
patients undergoing treatment with chemotherapy by 0.724 or 72.4%. Based on this 
explanation, it is suspected that there is no difference in the survival curve for the two 
treatment groups.  
To determine whether there is a difference in survival time on the type of treatment, the 
Log Rank test can be used. The calculation of the Log Rank test can use the formula in Equation 
(6). Breast cancer patients treated with radiotherapy have a higher survival rate than patients 
treated with chemotherapy. This is similar to a study conducted by Wijaya & Wulandari (2015) 
which showed that the two-year survival of breast cancer patients undergoing chemoradiation 
was higher than patients undergoing chemotherapy. Low survival of patients undergoing 
chemotherapy is usually associated with patients already in advanced condition when starting 








2. Log Rank Testing 
Furthermore, a log-rank test is used to determine if there is a difference between survival 
times. The following are the log-rank test results based on suspected factors to affect breast 
cancer patients' survival. 
Table 2. Log Rank Test Results 
Variables df 𝝌𝟐 Count 
Early Age Infected 3 3.745 
Clinical Stadium 1 105.977 
Tumor Size 1 96.633 
Metastasis 1 82.792 
Types of Treatment 1 2.360 
Based on the results of the log rank test, it can be known that the survival time of breast 
cancer patients based on the variable age of the initial infection (3.745 < χ2(0.05,3) = 7.815) 
and types of treatment (2.360 < χ2(0.05,1) = 3.841) there is no significant difference. 
Meanwhile, breast cancer patient survival time based on clinical stage variables (105.977 > 
χ2(0.05,1) = 3.841), tumor size (96.633 > χ2(0.05,1) = 3.841), metastasis (82.792 > χ2(0.05,1) 
= 3.841) there are significant differences in. 
 
3. Proportional Hazard Assumption Test 
Proportional hazard assumption testing is also conducted with the Goodness of Fit test 
approach. The Goodness of Fit test is performed to obtain more objective decisions. In this test, 
H0 noted that factors that are thought to affect breast cancer patients' survival meet 
proportional hazard assumptions. H1 believes that elements that are supposed to affect breast 
cancer patients' survival do not meet the proportional hazard assumptions. Here is the 
goodness of fit test for all factors thought to affect breast cancer patients' survival.  
Table 3. Goodness of Fit Test Results 
 
 Times 
Pearson Correlation Sig. (2 tailed) N 
Times 1  394 
Unstandardized 
Residual 
-0.231 0.000 394 
Early Age Infected 0.050 0.320 394 
Clinical Stadium 0.063 0.214 394 
Tumor Size 0.129 0.051 394 
Metastasis -0.092 0.069 394 
Types of Treatment 0.008 0.873 394 
 
Based on Table 3 obtained, the goodness of fit test results is a variable that meets the 
assumption of proportional hazard in all variables because the p-value of all variables is more 
significant than the α of 0.05. It is also claimed that it can be directly done modeling using cox 
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4. Cox Proportional Hazard regression 
Next is the creation of a model with cox proportional hazard regression. In this step 
obtained the results of regression as in Table 4  
Table 4. First Cox Proportional Hazard Regression Results 
 B SE df Sig. Exp(B) 
Early Age   3 0.337  
Early Age  (1) 0.487 0.643 1 0.448 1.628 
Early Age  (2) 0.887 0.501 1 0.077 2.428 
Early Age  (3) 0.640 0.502 1 0.202 1.896 
Clinical Stadium -1.334 0.758 1 0.078 0.263 
Tumor Size -1.293 0.379 1 0.001 0.274 
Metastasis 0.467 0.533 1 0.381 1.596 
 
From the results of the regression cox proportional hazard above can be obtained the first 
model, by using Equations (8), obtained the following results: 
ℎ(𝑡|𝑋) = ℎ0(𝑡) exp(0.487 𝑢𝑒𝑎𝑟𝑙𝑦 𝑎𝑔𝑒 𝑖𝑛𝑓𝑒𝑐𝑡𝑒𝑑 (1) + 0.887 𝑒𝑎𝑟𝑙𝑦 𝑎𝑔𝑒 𝑖𝑛𝑓𝑒𝑐𝑡𝑒𝑑(2)
+ 0.640 𝑒𝑎𝑟𝑙𝑦 𝑎𝑔𝑒 𝑖𝑛𝑓𝑒𝑐𝑡𝑒𝑑(3) − 1.334 𝑐𝑙𝑖𝑛𝑖𝑐𝑎𝑙 𝑠𝑡𝑎𝑑𝑖𝑢𝑚
− 1.293 𝑡𝑢𝑚𝑜𝑟 𝑠𝑖𝑧𝑒 + 0.467 𝑚𝑒𝑡𝑎𝑠𝑡𝑎𝑠𝑖𝑠 − 0.101 𝑡𝑦𝑝𝑒𝑠 𝑜𝑓 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡) 
 
5. Parameter Testing 
Parameter testing is conducted in two stages: simultaneous testing with the likelihood ratio 
test and partial testing with the Wald test. Parameter testing simultaneously with likelihood 
ratio test using the formula in Equation (9) is obtained as follows:  
𝜒𝐿𝑅
2 = 2 log 𝐿𝑣 − 2 log 𝐿0 = 587.276 − 508.382 = 78.894  
Because in the test, the likelihood ratio of the value 𝜒𝐿𝑅
2  78.894 greater than the  𝜒5;0.05
2  
11.071 can be concluded reject H0, meaning at least one variable significantly affects breast 
cancer patients' survival. After simultaneous testing is then conducted partial parameter 
testing with the Wald test, here is the following results on Table 5:  
Table 5. First Model Wald Test Results 
Variables 𝑿𝒘𝒂𝒍𝒅
𝟐  Decision 
Early Age  (1) 0.574 Receive H0 
Early Age  (2) 3.135 Reject H0 
Early Age  (3) 1.625 Receive H0 
Clinical Stadium 3.097 Reject H0 
Tumor Size 0.768 Receive H0 
Metastatic 11.639 Reject H0 
Types of Treatment 0.128 Receive H0 
 
Based on Table 5, it can be known that variables that have a significant effect or 𝜒𝑤𝑎𝑙𝑑
2  
greater than 𝜒1,0.10
2 = 2.706 is a variable of the initial age of cancer that is 41-50 years, the clinic 
stage, and the tumor's size. In contrast, the metastatic variables and types of treatment have no 
significant effect. 




Because there are some insignificant variables, those minor variables are excluded from the 
first model. Variables that significantly affected the first model have regressed Cox Proportional 
Hazard again and obtained results as in Table 6. 
Table 6. Second Cox Proportional Hazard Regression Results 
 B SE df Sig. Exp(B) 
Early Age  (2) 0.855 0.499 1 0.086 2.352 
Clinical Stadium -1.797 0.550 1 0.001 0.166 
Tumor Size -1.253 0.376 1 0.001 0.286 
 
From the results of the regression cox proportional hazard above can be obtained the 
second model using Equation (8), got the following results:  
ℎ(𝑡|𝑋) = ℎ0(𝑡) exp(0.855 𝑒𝑎𝑟𝑙𝑦 𝑎𝑔𝑒(2) − 1.797 𝑐𝑙𝑖𝑛𝑖𝑐𝑎𝑙 𝑠𝑡𝑎𝑑𝑖𝑢𝑚 − 1.253 𝑡𝑢𝑚𝑜𝑟 𝑠𝑖𝑧𝑒) 
 
After obtaining the second model will then be conducted parameter tests simultaneously 
and partially test parameters again. Parameter experimenting simultaneously with likelihood 
ratio test using the formula in Equation (9) obtained as follows:  
𝜒𝐿𝑅
2 = 2 log 𝐿𝑣 − 2 log 𝐿0 = 587.276 − 527.440 = 59.836  
 
Because in the test, the likelihood ratio of the value  𝜒𝐿𝑅
2 59.836 greater than the 𝜒5;0.05
2  7.815 
can be concluded reject H0, meaning there is at least one variable that significantly affects the 
survival of breast cancer patients. After simultaneous testing is then conducted partial 
parameter testing with the Wald test. Before calculating the test Wald, so obtained as follows 
on Table 7.  
Table 7. Second Model Wald Test Results 
Variables 𝑿𝒘𝒂𝒍𝒅
𝟐  Decision 
Early Age  (2) 2.936 Reject H0 
Clinical Stadium 10.675 Reject H0 
Tumor Size 11.105 Reject H0 
 
Based on Table 7 above obtained, all variables have a significant effect or  𝜒𝑤𝑎𝑙𝑑
2  greater than 
𝜒1,0.10
2 = 2.706 , so it can be said that the second regression model is the best model with 
variables that affect the survival of breast cancer patients is the variable of the initial age of 
cancer is 41-50 years, clinical stage, and tumor size. 
 
6. Hazard Ratio 
Furthermore, hazard ratio calculation to determine how much risk the group has on each 
variable that affects to die. The following is the result of the hazard ratio calculation. 
a. Hazard ratio variable early age of cancer is 41-50 years 
𝐻𝑅 =
𝐻(720)UAT 41−50 years old




= 0.424  
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From the hazard ratio, it can be said that the probability of breast cancer patients with 
early age infected is 51-60 years to survive within two years is 2.358 times (1/0.424) 
compared to breast cancer patients with an early age of 41-50 years. 
 







= 0.166  
 
From the hazard ratio, it can be said that the chances of early-stage breast cancer 
patients to survive within two years is 6.024 times (1/0.166) compared to advanced 
breast cancer patients. 
 
c. Hazard ratio variable tumor size 
𝐻𝑅 =
𝐻(2) > 5 𝑐𝑚






From the hazard ratio results, it can be said that the probability of breast cancer patients 
who have a tumor size of ≤5 cm survive within two years is 3.497 times (1/0.286) compared to 
breast cancer patients who have a tumor size of >5 cm. 
 
D. CONCLUSION AND SUGGESTIONS 
From the processing and analysis of data discussed before, it can be concluded that, based 
on the results of calculations, the probability of survival of breast cancer patients (with a sample 
of 394 patients over two years) was 0.737 or 73.7%. When reviewed from the variable of the 
initial age of infection then the probability of survival of breast cancer patients when the initial 
age of disease is 31-40 years of age by 0.656 or 65.6%, 41-50 years of 0.747 or 74.7%, 51-60 
years of 0.801 or 80.1%, and >60 years of 0.778 or 77.8%.  
The probability of survival of breast cancer patients based on early-stage variables is 0.944 
or 94.4%, and the advanced stage is 0.503 or 50.3%. The probability of survival of breast cancer 
patients based on variable tumor size ≤5 cm is 0.877 or 87.7%, and that has a tumor size of 
0.434 cm or 43.4%. The probability of survival of breast cancer patients with metastasis is 
0.527 or 52.7%, and that there is no metastasis of 0.907 or 90.7%. The probability of survival 
of breast cancer patients based on variable types of radiotherapy treatment is 0.792 or 79.2%, 
and the type of chemotherapy treatment is 0.724 or 72.4%. Therefore, the variables that 
significantly affect breast cancer patients' survival are the initial age of infection, the stage of 
the clinic, and the size of the tumor. 
In this study, patient data were analyzed in the two-year study. For further research, we 
recommend using data with objects observed over a more extended period, for example, for 
five years. The survival analysis results get a more objective picture. Also, observed variables 
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